Recent and emerging anti‐diabetes targets
- 14 October 2008
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 29 (1) , 125-195
Abstract
Diabetes is a disease that affects over 150 million people worldwide for which there are multiple oral and injectable medications. Because of trends in obesity and sedentary lifestyles, diabetes rates in both developed and developing countries are increasing at an alarming rate. Current medications are not adequately effective in maintaining long‐term glycemic control in most patients, even when used in combination, leaving diabetics susceptible to developing life threatening and debilitating complications such as cardiovascular disease, blindness, kidney complications, and amputations. Consequently, there is a critical need for more potent pharmacotherapies with novel mechanisms of action. A panel of 20 emerging diabetes targets is presented, and small molecule modulators for each target will be discussed. © 2008 Wiley Periodicals, Inc. Med Res Rev, 29, No. 1, 125–195, 2009Keywords
This publication has 309 references indexed in Scilit:
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targetsNature Reviews Drug Discovery, 2008
- Prevention and treatment of type 2 diabetes: Current role of lifestyle, natural product, and pharmacological interventionsPharmacology & Therapeutics, 2008
- An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemiaBritish Journal of Pharmacology, 2007
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- PPARδ as a therapeutic target in metabolic diseaseFEBS Letters, 2007
- Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein KinaseJournal of Biological Chemistry, 2007
- Glyceraldehyde 3-Phosphate Dehydrogenase Is a Cellular Target of the Insulin Mimic Demethylasterriquinone B1Journal of Medicinal Chemistry, 2007
- A two stage click-based library of protein tyrosine phosphatase inhibitorsBioorganic & Medicinal Chemistry, 2007
- Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzymeBritish Journal of Pharmacology, 2006
- Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small moleculesBritish Journal of Pharmacology, 2006